We are live on ! Find out more
RCP

Rho Capital Partners Portfolio holdings

AUM $20.4M
This Fund
S&P 500
This Quarter Est. Return
+5.54%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$257M
AUM Growth
+$1.21M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
6
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 22.42%
2 Healthcare 17.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVDY
1
DELISTED
Everyday Health, Inc.
EVDY
$109M 42.42%
5,908,432
IL
2
DELISTED
IntraLinks Holdings Inc.
IL
$57.7M 22.42%
6,490,503
TVRD
3
Tvardi Therapeutics
TVRD
$24M
$45.4M 17.64%
74,113
ANAC
4
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$18.9M 7.36%
1,067,892
RLOC
5
DELISTED
REACHLOCAL INC COM STK (DE)
RLOC
$18.1M 7.02%
2,570,395
NRX
6
DELISTED
NEPHROGENEX INC COM
NRX
$8.07M 3.13%
1,326,826

Similar funds

Rho Capital Partners's Q2 2014 Portfolio in Review

As of Q2 2014, Rho Capital Partners held 6 positions worth $257M, up 0.47% from $256M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2014: portfolio turnover was 0%. Rho Capital Partners opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 26% a quarter earlier, followed by Healthcare.

  • Rho Capital Partners's ten largest holdings make up 100% of its $257M portfolio in Q2 2014.
  • Rho Capital Partners opened 0 new positions and closed 0 in Q2 2014.
  • Rho Capital Partners's portfolio value rose 0.47% quarter-over-quarter to $257M.

Based on Rho Capital Partners's 13F filing for Q2 2014, filed 22 Jul 2014.